Investors looking for stocks in the Mining - Gold sector might want to consider either Barrick Gold (GOLD) or Alamos Gold (AGI) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong ea ...

A financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news surrounding the industry, and strive to provide readers with ample research and investment opportunities.Analyst’s Disclosure: I/we have a beneficial long position in the shares of FDUS either through stock ownership, options, or other derivatives. I wrote this ...

Core Viewpoint - Holcim Ltd Unsponsored ADR (HCMLY) is currently viewed as a better value opportunity compared to Knife River (KNF) based on various financial metrics and rankings [1][3]. Group 1: Zacks Rank and Earnings Outlook - Holcim Ltd has a Zacks Rank of 2 (Buy), indicating a strong earnings outlook, while Knife River has a Zacks Rank of 4 (Sell) [3]. - The improvement in earnings outlook for HCMLY is stronger than that of KNF, making it more appealing for value investors [3]. Group 2: Valuation Metrics - HCMLY has a forward P/E ratio of 15.22, significantly lower than KNF's forward P/E of 23.57, suggesting that HCMLY is undervalued relative to KNF [5]. - The PEG ratio for HCMLY is 2.20, while KNF's PEG ratio is slightly higher at 2.26, indicating that HCMLY may offer better value considering its expected earnings growth [5]. - HCMLY's P/B ratio stands at 1.97, compared to KNF's P/B of 3.65, further supporting the argument that HCMLY is the superior value option [6]. Group 3: Value Grades - Based on the analysis of various valuation metrics, HCMLY holds a Value grade of B, while KNF has a Value grade of C, reinforcing HCMLY's position as the better value investment [6].

Core Viewpoint - Gilead Sciences (GILD) is currently viewed as a more attractive undervalued stock option compared to Amgen (AMGN) based on various financial metrics and earnings outlook [1][7]. Valuation Metrics - GILD has a forward P/E ratio of 14.24, while AMGN's forward P/E is 15.10, indicating GILD may be undervalued relative to AMGN [5]. - The PEG ratio for GILD is 0.73, suggesting a favorable valuation when considering expected earnings growth, compared to AMGN's PEG ratio of 2.60 [5]. - GILD's P/B ratio stands at 7.26, significantly lower than AMGN's P/B ratio of 28.50, further supporting GILD's valuation as more attractive [6]. Earnings Outlook - GILD is experiencing an improving earnings outlook, which enhances its position in the Zacks Rank model, indicating a positive trend in earnings estimates [3][7].

Group 1 - JD.com, Inc. has a Zacks Rank of 1 (Strong Buy), indicating a more favorable earnings estimate revision activity compared to eBay, which has a Zacks Rank of 3 (Hold) [3] - Value investors typically analyze various traditional metrics to identify undervalued stocks, including P/E ratio, P/S ratio, earnings yield, and cash flow per share [4] - JD has a forward P/E ratio of 8.74, significantly lower than eBay's forward P/E of 12.67, and a PEG ratio of 0.27 compared to eBay's 1.97, suggesting better value for JD [5] Group 2 - JD's P/B ratio stands at 1.53, while eBay's P/B ratio is much higher at 6.24, further supporting JD's superior valuation metrics [6] - Overall, JD has demonstrated stronger estimate revision activity and more attractive valuation metrics than eBay, making it a more appealing option for value investors [7]